Sequential cyclophosphamide (C)-prednisone (P) and vincristine (V)-bleomycin (B): An effective schedule-dependent treatment for advanced diffuse histiocytic lymphoma (DH)

G. J. Johnson, W. B. Costello, M. M. Oken

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Sequential cyclophosphamide (C)-prednisone (P) and vincristine (V)-bleomycin (B): An effective schedule-dependent treatment for advanced diffuse histiocytic lymphoma (DH)'. Together they form a unique fingerprint.